BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Pro-Dex, Inc. (PDEX) Appoints Michael J. Berthelot Chief Executive Officer


4/23/2012 6:47:37 AM

IRVINE, Calif., April 20, 2012 /PRNewswire/ -- PRO-DEX, INC. (Nasdaq: PDEX) announced today that it had appointed Michael J. Berthelot to the position of Chief Executive Officer, effective immediately. The Company also announced that Mark P. Murphy had resigned from all positions with the Company and its subsidiaries, including his positions as Chief Executive Officer and President and as a member of the Company's Board of Directors, effective today.

(Logo: http://photos.prnewswire.com/prnh/20111025/LA93174LOGO-c)

Mr. Berthelot, 61, has served on the Company's Board of Directors since 2009, chairing the Governance and Nominating Committee and serving as a member of the audit and compensation committees. Mr. Berthelot is the Chief Executive Officer of Cito Capital Corporation, a consulting firm that provides operational, financial, and strategic advice to businesses and Managing Principal of Corporate Governance Advisors Inc., a firm which provides advice to small public companies on matters concerning corporate governance. Mr. Berthelot previously served for 13 years as the Chairman and Chief Executive Officer and an additional 3 years as non-executive Chairman of TransTechnology Corporation, a $350 million (revenues) NYSE listed multinational manufacturer of aerospace and industrial products. Mr. Berthelot is also an adjunct faculty member at the University of California San Diego's Rady School of Management where he teaches a course on the board, the CEO, and corporate governance in the MBA program. Mr. Berthelot is a CPA and holds a B.S. in Accounting from the University of Akron and an MBA from Cleveland State University.

William Healey, Chairman of the Company's Board of Directors, commented, "We welcome Mike's leadership in guiding Pro-Dex through a time of major change. His breadth of experiences in finance and operations and his ability to think both strategically and tactically will be valuable additions to our company." Mr. Healey continued, "We also thank Mark Murphy for his six years of service and for the contributions he has made in preparing our company for its next phase. We wish Mark well in whatever he may pursue in the future."

"I am honored to be asked to take on this assignment and am excited about the future of Pro-Dex," said Mr. Berthelot "Our Company has a stellar reputation in its markets, first rate associates, and a strong balance sheet. I am looking forward to working with our management team, associates, customers and partners as we develop the course forward to build great products for our customers, solid futures for our associates, and sustainable value for our shareholders."

Pro-Dex, Inc., with operations in California and Oregon, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate powered surgical device drive and embedded motion control systems serving the medical, dental, semi-conductor and scientific research markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities and high tech manufacturing operations around the world. For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.

SOURCE Pro-Dex, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES